Armando López-Guillermo Selected Research

Armando López-Guillermo Research Topics

Disease

36	Neoplasms (Cancer) 01/2024 - 06/2002
27	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2023 - 11/2002
18	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 06/2002
17	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2023 - 09/2002
16	Lymphoma (Lymphomas) 02/2023 - 04/2003
12	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2024 - 11/2004
7	B-Cell Lymphoma (Lymphoma, B Cell) 01/2024 - 01/2004
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2023 - 10/2002
5	Hodgkin Disease (Hodgkin's Disease) 02/2023 - 09/2002
5	Infections 11/2021 - 03/2003
4	Residual Neoplasm 10/2022 - 11/2002
3	Cytopenia 01/2022 - 03/2003
3	Disease Progression 01/2019 - 11/2004
2	Multiple Myeloma 01/2021 - 01/2020
2	Second Primary Neoplasms (Neoplasms, Second) 10/2017 - 10/2011
2	Cryoglobulinemia 03/2004 - 08/2003
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 02/2023
1	Lymphadenopathy 01/2022
1	Lymphopenia (Lymphocytopenia) 11/2021
1	Invasive Fungal Infections 11/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 04/2020
1	Febrile Neutropenia 01/2018
1	Trisomy (Trisomies) 01/2018
1	Neutropenia 01/2018

Drug/Important Bio-Agent (IBA)

26	Rituximab (Mabthera)FDA Link 10/2022 - 01/2004
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2017 - 09/2002
7	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 09/2004
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2002
7	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2012 - 05/2006
6	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2002
5	Vincristine (Oncovin)FDA LinkGeneric 09/2012 - 05/2006
5	Prednisone (Sone)FDA LinkGeneric 09/2012 - 05/2006
4	RNA (Ribonucleic Acid)IBA 10/2023 - 02/2014
4	ibrutinibIBA 01/2023 - 02/2016
4	Cyclin D1IBA 01/2021 - 09/2013
4	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2017 - 09/2002
4	Messenger RNA (mRNA)IBA 12/2011 - 01/2006
3	idelalisibIBA 11/2021 - 02/2016
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019 - 10/2002
3	Bendamustine Hydrochloride FDA Link 01/2019 - 02/2016
3	Etoposide (VP 16)FDA LinkGeneric 01/2019 - 10/2002
3	ChromatinIBA 01/2018 - 11/2013
3	Lenalidomide (CC 5013)FDA Link 01/2018 - 04/2016
3	fludarabineIBA 04/2017 - 09/2002
3	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 06/2002
2	Long Noncoding RNAIBA 10/2023 - 01/2019
2	Interleukin-1 Receptor-Associated KinasesIBA 12/2022 - 10/2021
2	Protein Isoforms (Isoforms)IBA 12/2022 - 01/2018
2	Cell-Free Nucleic AcidsIBA 06/2022 - 01/2021
2	Monoclonal AntibodiesIBA 11/2021 - 03/2017
2	venetoclaxIBA 11/2021 - 01/2020
2	CyclinsIBA 01/2021 - 11/2009
2	daratumumabIBA 01/2020 - 03/2017
2	CytokinesIBA 01/2020 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2017
2	CryoglobulinsIBA 01/2017 - 03/2003
2	Bleomycin (Blenoxane)FDA LinkGeneric 10/2009 - 02/2007
2	Dacarbazine (DIC)FDA LinkGeneric 10/2009 - 02/2007
2	Vinblastine (Vinblastine Sulfate)FDA Link 10/2009 - 02/2007
2	Ifosfamide FDA LinkGeneric 04/2003 - 10/2002
2	Dexamethasone (Maxidex)FDA LinkGeneric 10/2002 - 09/2002
1	axicabtagene ciloleucelIBA 01/2024
1	Chimeric Antigen ReceptorsIBA 10/2023
1	Programmed Cell Death 1 ReceptorIBA 02/2023
1	isatuximabIBA 02/2023
1	cemiplimabIBA 02/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	Liver X ReceptorsIBA 12/2022
1	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2022
1	Hexachlorobenzene (HCB)IBA 01/2022
1	ibritumomab tiuxetan (Zevalin)FDA Link 01/2022
1	Serum AlbuminIBA 01/2022
1	CD40 Ligand (CD40L)IBA 12/2021
1	ofatumumab FDA Link 11/2021
1	obinutuzumabIBA 11/2021
1	acalabrutinibIBA 11/2021
1	NivolumabIBA 11/2021
1	pembrolizumabIBA 11/2021
1	Circulating Tumor DNAIBA 01/2021
1	Macrophage Colony-Stimulating FactorIBA 01/2021
1	A-Form DNA (A-DNA)IBA 11/2020
1	Anaplastic Lymphoma KinaseIBA 04/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	SuspensionsIBA 01/2019
1	CPI203IBA 01/2019
1	Melphalan (Alkeran)FDA LinkGeneric 01/2019
1	Carmustine (FIVB)FDA Link 01/2019
1	Chemokine ReceptorsIBA 01/2019
1	Agammaglobulinaemia Tyrosine KinaseIBA 11/2017
1	spebrutinibIBA 11/2017
1	Dihydrotachysterol (AT 10)IBA 10/2017

Therapy/Procedure

21	Therapeutics 01/2022 - 11/2002
19	Drug Therapy (Chemotherapy) 01/2024 - 06/2002
10	Stem Cell Transplantation 12/2019 - 10/2002
5	Immunotherapy 01/2023 - 01/2018
3	Salvage Therapy 01/2023 - 04/2003
3	Highly Active Antiretroviral Therapy (HAART) 02/2008 - 09/2002
2	Secondary Prevention 12/2019 - 12/2018
1	Transplantation 01/2024